- Home
- / Aviragen Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Aviragen Therapeutics does not have financial data available on financial statements or acquisitions and subsidiaries.
Stock Price
$8.4
2022-08-04
Market Capitalization
$705.2 M
2022-08-04
CreditSafe Score
?
Score changed on Jul 20, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more